Stay updated on ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial
Sign up to get notified when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.

Latest updates to the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check14 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check56 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check64 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check78 days agoChange DetectedThe date on the webpage has been updated from February 13, 2025, to March 25, 2025.SummaryDifference0.6%
Stay in the know with updates to ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.